Eli Lilly and Company LLY Competitive Headwinds Mount As Novo Nordisk Gains GLP1 Market Traction What Rand RAND does that its rivals cannot replicate Rand posts 033 EPS on strong private portfolio gains USBR US management prioritizes steady preferred dividend payouts for holders amid broad market volatility Why Winmark Corporation WINA might be early to something big Weakens 20260506 Why CompX CIX is trading below its true worth Investor Concern 20260508 SWVL Swvl reports far narrower Q4 2022 loss than analyst estimates shares hold steady How Smith SMSI is reshaping its industry Slight Loss 20260506 SUPN Supernus Pharmaceuticals delivers huge Q4 2025 EPS beat but shares dip 113 percent in todays trading